Does End-Stage Renal Disease (ESRD) cause hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does End-Stage Renal Disease (ESRD) Cause Hypotension?

Yes, ESRD commonly causes hypotension, particularly during hemodialysis sessions, with intradialytic hypotension occurring in 25-50% of dialysis treatments. 1

Mechanisms of Hypotension in ESRD

ESRD can lead to hypotension through several mechanisms:

  1. Dialysis-related factors:

    • Rapid ultrafiltration during hemodialysis
    • Removal of fluid exceeding plasma refill rate
    • Dialysate sodium concentration imbalances
    • Core body temperature increases during dialysis 1
  2. Patient-specific factors:

    • Autonomic dysfunction (common in ESRD patients)
    • Cardiac disease and impaired cardiac reserve
    • Medication effects (particularly antihypertensive medications)
    • Poor vascular compliance 1, 2

Clinical Presentation and Consequences

Hypotension in ESRD manifests in two main patterns:

  1. Intradialytic hypotension (IDH):

    • Occurs during 25-50% of hemodialysis treatments
    • Symptoms include nausea, muscle cramps, dizziness, and syncope
    • Can lead to ischemic injury to vital organs 1
  2. Chronic hypotension:

    • Predialysis systolic BP <110 mmHg or diastolic BP <70 mmHg
    • Associated with increased mortality risk 2

The consequences of hypotension in ESRD patients are significant:

  • Increased mortality risk (71.43% higher odds of death with intradialytic events) 3
  • Myocardial ischemia and stunning
  • Cerebrovascular complications
  • Vascular access thrombosis
  • Inadequate dialysis due to shortened sessions 1, 3

Management Strategies

Prevention of Hypotension in ESRD:

  1. Dialysis prescription modifications:

    • Longer, slower hemodialysis sessions
    • Short daily hemodialysis or nocturnal hemodialysis
    • Careful assessment of dry weight
    • Avoiding excessive ultrafiltration rates (keep below 6 ml/h per kg) 4, 2
  2. Sodium and fluid management:

    • Consider liberalizing salt intake in patients prone to hypotension
    • Individualized dialysate sodium concentration
    • Careful fluid management between sessions 4, 5
  3. Medication adjustments:

    • Adjust or temporarily suspend antihypertensive medications before dialysis
    • Prefer short-acting agents that allow for rapid adjustments 4
    • Consider timing of antihypertensive medications in relation to dialysis sessions 6

Treatment of Established Hypotension:

  1. Pharmacologic interventions:

    • Midodrine (alpha-1 adrenergic agonist) 10mg orally 30 minutes before dialysis has shown effectiveness and safety over extended periods 7
    • Beta-blockers and calcium channel blockers may be protective against mortality in patients with intradialytic events 3
  2. Dialysis adjustments during hypotensive episodes:

    • Reduce or pause ultrafiltration
    • Administration of isotonic saline
    • Trendelenburg positioning
    • Oxygen supplementation if needed 5, 1

Monitoring Recommendations

  1. Blood pressure monitoring:

    • Monitor BP continuously during dialysis
    • Establish individualized blood pressure targets
    • Consider home BP monitoring between sessions 4, 2
  2. Assessment for orthostatic hypotension:

    • Check for symptoms of orthostatic hypotension
    • Assess BP patterns both during and between dialysis sessions 4
  3. Regular cardiovascular evaluation:

    • Yearly echocardiography to assess cardiac function
    • Evaluation of volume status 2

While hypertension is more commonly associated with ESRD (affecting the majority of patients), hypotension represents a significant clinical challenge that impacts morbidity and mortality. Proper management requires careful attention to dialysis prescription, medication management, and individualized care planning.

References

Research

Setting the stage.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Research

Hemodialysis-associated hypertension: pathophysiology and therapy.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002

Research

Intradialytic Hypertension / Hypotension and Mortality in San Juan, Puerto Rico.

Boletin de la Asociacion Medica de Puerto Rico, 2016

Guideline

Management of End-Stage Renal Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.